Literature DB >> 19369701

Deletion polymorphism of SIGLEC14 and its functional implications.

Masahiro Yamanaka1, Yukinari Kato, Takashi Angata, Hisashi Narimatsu.   

Abstract

Human Siglec-14, a member of the Siglec family of sialic acid-binding lectins, shows extensive sequence similarity to human Siglec-5. To analyze respective expression patterns of Siglec-14 and Siglec-5, we developed specific antibodies against each of them. We found that the former was expressed on granulocytes and monocytes, while the latter was on granulocytes and B-cells. Surprisingly, some individuals lacked the expression of Siglec-14, while they all expressed Siglec-5. We found that a fusion between SIGLEC14 and SIGLEC5 genes, resulting in the functional deletion of SIGLEC14, underlies this phenotype. The presence of the "SIGLEC14 null" allele in all human populations we tested implies an ancient origin, while its allelic frequency is higher in Asians compared with Africans and Europeans. The forced expression of Siglec-14 in a monocytic cell line-enhanced TNF-alpha secretion elicited by lipopolysaccharide. These results imply that Siglec-14 may play some role in bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369701     DOI: 10.1093/glycob/cwp052

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  40 in total

Review 1.  Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

Authors:  Huan Cao; Paul R Crocker
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

Review 2.  Siglecs as sensors of self in innate and adaptive immune responses.

Authors:  James C Paulson; Matthew S Macauley; Norihito Kawasaki
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

3.  Natural ligands for CD33-related Siglecs?

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2009-05-09       Impact factor: 4.313

4.  Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses.

Authors:  Rie Suematsu; Tomofumi Miyamoto; Shinobu Saijo; Sho Yamasaki; Yoshifumi Tada; Hiroki Yoshida; Yasunobu Miyake
Journal:  J Biol Chem       Date:  2019-09-24       Impact factor: 5.157

5.  Relating CNVs to transcriptome data at fine resolution: assessment of the effect of variant size, type, and overlap with functional regions.

Authors:  Andreas Schlattl; Simon Anders; Sebastian M Waszak; Wolfgang Huber; Jan O Korbel
Journal:  Genome Res       Date:  2011-08-23       Impact factor: 9.043

6.  Colloquium paper: uniquely human evolution of sialic acid genetics and biology.

Authors:  Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

Review 7.  Evaluation of CD33 as a genetic risk factor for Alzheimer's disease.

Authors:  Steven Estus; Benjamin C Shaw; Nicholas Devanney; Yuriko Katsumata; Eileen E Press; David W Fardo
Journal:  Acta Neuropathol       Date:  2019-04-04       Impact factor: 17.088

8.  Genetic variants in PLG, LPA, and SIGLEC 14 as well as smoking contribute to plasma plasminogen levels.

Authors:  Qianyi Ma; Ayse B Ozel; Shweta Ramdas; Beth McGee; Rami Khoriaty; David Siemieniak; Hong-Dong Li; Yuanfang Guan; Lawrence C Brody; James L Mills; Anne M Molloy; David Ginsburg; Jun Z Li; Karl C Desch
Journal:  Blood       Date:  2014-09-10       Impact factor: 22.113

Review 9.  Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses.

Authors:  Heinz Läubli; Ajit Varki
Journal:  Cell Mol Life Sci       Date:  2019-09-04       Impact factor: 9.261

10.  Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.

Authors:  Bao Hoa Duong; Hua Tian; Takayuki Ota; Gladys Completo; Shoufa Han; José Luis Vela; Miyo Ota; Michael Kubitz; Nicolai Bovin; James C Paulson; James Paulson; David Nemazee
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.